SMTL ID : 4hhz.1 (3 other biounits)

Crystal structure of PARP catalytic domain in complex with novel inhibitors

Coordinates

PDB Format Compare

Method

X-RAY DIFFRACTION 2.72 Å

Oligo State

monomer

Ligands

1 x 15S: N-{(2S)-1-[4-(4-fluorophenyl)-3,6-dihydropyridin-1(2H)-yl]-1-oxopropan-2-yl}-2-[(9aR)-7-oxo-2,3,7,8,9,9a-hexahydro-1H-benzo[de][1,7]naphthyridin-1-yl]acetamide(Non-covalent)

15S.1: 19 residues within 4Å: Chain A: Y.54, D.110, L.113, W.205, H.206, G.207, R.222, I.223, A.224, P.225, Y.233, G.238, Y.240, F.241, A.242, K.247, S.248, Y.251, E.332 12 PLIP interactions: 12 interactions with chain A Hydrophobic interactions: A:D.110, A:L.113, A:R.222, A:A.224, A:Y.233, A:Y.240, A:A.242, A:K.247, A:Y.251 Hydrogen bonds: A:G.207, A:G.207 pi-Cation interactions: A:Y.251

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Ye, N. et al., Design, Synthesis, and Biological Evaluation of a Series of Benzo[de][1,7]naphthyridin-7(8H)-ones Bearing a Functionalized Longer Chain Appendage as Novel PARP1 Inhibitors. J.Med.Chem. (2013)

Release Date

2013-03-27

Peptides

Poly [ADP-ribose] polymerase 1: A

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
C

Poly [ADP-ribose] polymerase 1

Related Entries With Identical Sequence